Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Harrington

Showing results (361-370 of 453) with videos related to

Pageof 46
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the ratK J Stanhope, N R Mirza, M J Bickerdike, et al.
The American Journal of Pathology|August 10, 2000
Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's diseaseE B Mukaetova-Ladinska, F Garcia-Siera, J Hurt, et al.
Journal of Alzheimer'S Disease : JAD|June 16, 2020
Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's DiseaseMario Hernandes-Alejandro, Sarita Montaño, Charles R Harrington, et al.
Thescientificworldjournal|December 22, 2009
Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobeElizabeta B Mukaetova-Ladinska, John H Xuereb, Francisco Garcia-Sierra, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Metabolic control of adaptive β-cell proliferation by the protein deacetylase SIRT2Matthew Wortham, Bastian Ramms, Chun Zeng, et al.
The Journal of Biological Chemistry|March 12, 2015
Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer DiseaseCharles R Harrington, John M D Storey, Scott Clunas, et al.
Developmental Cell|April 11, 2023
Understanding cell fate acquisition in stem-cell-derived pancreatic islets using single-cell multiome-inferred regulomesHan Zhu, Gaowei Wang, Kim-Vy Nguyen-Ngoc, et al.
International Journal of Molecular Sciences|April 30, 2021
Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer's Disease BrainsLuis O Soto-Rojas, B Berenice Campa-Córdoba, Charles R Harrington, et al.
Journal of Alzheimer'S Disease : JAD|August 20, 2019
Phospho-Tau Protein Expression in the Cell Cycle of SH-SY5Y Neuroblastoma Cells: A Morphological StudyPaola Flores-Rodríguez, Charles R Harrington, Claude M Wischik, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 26, 2020
Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor studyL A DiMeglio, L G Kanapka, D J DeSalvo, et al.
Pageof 46

Showing results (361-370 of 453) with videos related to

Sort By:
Pageof 46
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the ratK J Stanhope, N R Mirza, M J Bickerdike, et al.
The American Journal of Pathology|August 10, 2000
Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's diseaseE B Mukaetova-Ladinska, F Garcia-Siera, J Hurt, et al.
Journal of Alzheimer'S Disease : JAD|June 16, 2020
Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's DiseaseMario Hernandes-Alejandro, Sarita Montaño, Charles R Harrington, et al.
Thescientificworldjournal|December 22, 2009
Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobeElizabeta B Mukaetova-Ladinska, John H Xuereb, Francisco Garcia-Sierra, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Metabolic control of adaptive β-cell proliferation by the protein deacetylase SIRT2Matthew Wortham, Bastian Ramms, Chun Zeng, et al.
The Journal of Biological Chemistry|March 12, 2015
Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer DiseaseCharles R Harrington, John M D Storey, Scott Clunas, et al.
Developmental Cell|April 11, 2023
Understanding cell fate acquisition in stem-cell-derived pancreatic islets using single-cell multiome-inferred regulomesHan Zhu, Gaowei Wang, Kim-Vy Nguyen-Ngoc, et al.
International Journal of Molecular Sciences|April 30, 2021
Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer's Disease BrainsLuis O Soto-Rojas, B Berenice Campa-Córdoba, Charles R Harrington, et al.
Journal of Alzheimer'S Disease : JAD|August 20, 2019
Phospho-Tau Protein Expression in the Cell Cycle of SH-SY5Y Neuroblastoma Cells: A Morphological StudyPaola Flores-Rodríguez, Charles R Harrington, Claude M Wischik, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 26, 2020
Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor studyL A DiMeglio, L G Kanapka, D J DeSalvo, et al.
Pageof 46